Summit's SMT C1100 gives more hope in that it has the potential to treat all patients with DMD despite the underlying causes of the condititon. How long before it gets into the market only God knows. Wishing the team well.
You can share this discussion in two ways…
Share this link:
Send it with your computer's email program: Email this